Two distinct activator proteins for lipoprotein lipase (LPL) have been isolated in approximately equal amounts from ovine plasma. These low molecular weight proteins were readily separated from each other on the basis of size and charge. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis indicated proteins of Mr about 8000 and 5000, with pI in urea-containing gels of about 5·1 and 4·8 respectively. Each of the ovine activator proteins was as effective as human apolipoprotein C-II (apo C-II) in activating LPL, with I JLg/ml giving near to maximum activation, and in lowering the apparent Km of LPL for triolein substrate. As the ratio of activator to triolein increased from 0·16 to 5· 2 (JLg/mg) the apparent Km fell from about O' 5 to 0 ·18 mM. Whereas human apo C-II and the two ovine activators were equally effective in stimulating the hydrolysis of triolein, differences were observed between the human and ovine activators when p-nitrophenylbutyrate was used as substrate. Unlike human apo C-II, which produced significant inhibition of p-nitrophenylbutyrate hydrolysis, the ovine activators were without effect. This suggests that the interaction between the ovine activators and LPL is different from that of human apo C-II.
Introduction
Lipoprotein lipase (EC 3.1.1.34; triacylglyceroprotein acylhydrolase; LPL), bound to the lumenal surfaces of endothelial cells lining the blood capillaries of extrahepatic tissues, determines the rate of hydrolysis of triacylglycerols (TAG) in the plasma. Because of its location and tissue variation in activity, LPL acts as a regulatory enzyme for the uptake of lipid into peripheral tissues. One of the proteins associated with the natural substrates [very low density lipoprotein (VLDL) and chylomicronsl is required for maximal rate of hydrolysis. This protein isolated from human plasma has been designated apolipoprotein C-1I (apo C-II) (Havel et al. 1970; La Rosa et al. 1970) .
In our studies on the deposition of fat in ruminant animals of economic importance, we have investigated the regulatory role of LPL in ovine adipose tissue and its activation by component(s) of ovine serum. Recently we have shown that not only do ovine adipose tissues contain very significant levels of LPL activity but that ovine serum is a particularly good source of activator(s) at or below physiological substrate concentrations (Tume et al. 1983; Tume and Thornton 1985) . Human apo C-1I has been widely studied and well characterized (see Quinn et al. 1982a) . Other preparations of LPL activators have been made from egg yolk lipoproteins and from pig plasma . Several groups of workers have investigated the various effectors of LPL from bovine serum (Lim and Scanu 1976; Clegg 1978) and plasma (Astrup and Bengtsson 1982) . Whereas human, rat and porcine plasma contain only one activator of LPL, bovine plasma and egg yolk lipoproteins have been shown to contain at least two activators. To date, no studies have been reported for ovine serum.
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Compared with human serum, bovine and ovine serum contain relatively low concentrations of both TAG (Tume and Thornton 1985) and VLDL (Nelson 1973) , and much of the activator protein is associated with high density lipoprotein (HDL) (Lim and Scanu 1976) . Whereas considerable ultracentrifugation time is generally required in the initial steps of the standard isolation procedures for LPL activator proteins, a more rapid technique based on the ability of certain apoproteins to bind to synthetic lipid particles (Erkelens et al. 1979; Carlson 1980) has been developed by Astrup and Bengtsson (1982) .
In these experiments we have made use of the method described by Astrup and Bengtsson (1982) to isolate, purify and partially characterize two components of ovine plasma that exhibit strong activation of LPL.
Materials and Methods

Preparation of Ovine Plasma
Blood was collected from sheep being slaughtered at a local abattoir. Blood from individual sheep was treated with trisodium citrate (5' 8 gil) and then pooled (10 litres) in a large polyethylene container. On returning to the laboratory the blood was chilled and plasma prepared by centrifugation at about 4°C (1500 g, 30 min). The plasma was removed and immediately 5,5'-dithio-bis(2-nitrobenzoic acid) (0' 6 mg/ml), phenylmethylsulfonyl fluoride (0' 35 mg/ml), sodium azide (0'13 mg/ml) and EDT A (0' 37 mg/ml) were added at the concentrations indicated.
Preparation of Washed Intralipid
Intralipid, 20% (w/v) (Kabi Vitrum, Stockholm, Sweden), was washed to remove excess phospholipid as described by Astrup and Bengtsson (1982) . The final washed fat cake resulting from 1 litre of Intralipid was resuspended in 0·15 M NaCI, 0·1 M Tris-HCI (pH 7 '4) to a total volume of 200 ml.
Binding of Plasma Proteins to Washed Intralipid
The method of Astrup and Bengtsson (1982) was used with some modification. Five litres of plasma were warmed to 25°C, and 200 ml of washed Intralipid suspension added, and the mixture stirred gently for 30 min. Following the binding step, all other procedures were done at 0-4°C. The washed Intralipid containing the bound proteins was isolated by centrifugation (28000 g/90 min). The fat cake was carefully recovered, resuspended in 200 ml 0·15 M NaCI, 0·1 M Tris-HCI (pH 7'4),10% (v/v) sucrose, layered below 4 volumes of 0·15 M NaCI, 0·1 M Tris-HCI (pH 7·4), and centrifuged again as described. The fat cake was washed at least three times or until no pellet was visible.
Isolation of Delipidated Proteins
The washed fat cake was transferred to a stainless steel beaker and mixed with 400 ml chloroform until a smooth paste was obtained. A clear solution was formed by adding 800 ml of chloroformmethanol (1: 1, v/v). However, on standing for 2 h at O°C a flocculant precipitate formed. This was collected by filtration on a Whatman No.1 paper, washed with 150 ml chloroform-methanol (2: 1, v/v), then 100 ml diethyl ether, dried, and stored at -20°C in a desiccator. Usually ==200 mg dried powder (apoproteins) was obtained per litre of plasma.
Gel Filtration of Apoproteins
Apoproteins (== 400 mg protein) were dissolved in 5 ml of 4 M guanidine-HCI, 0·2 M Tris-HCI, (pH 8'2), 0'1% (w/v) sodium azide, 5 mM dithiothreitol, and applied to a Sephadex G-200 Superfine (Pharmacia) column (2' 5 by 100 cm) previously equilibrated in the same buffer. The apoproteins were eluted from the column using the same solvent, and fractions were assayed for activator, pooled, dialysed into 0·01 M Tris-H CI (pH 7· 2) and lyophilysed.
Ion-exchange Chromatography of Apoproteins
Peak 3 from the Sephadex G-200 column contained the C group of apoproteins as evidenced by SDS-polyacrylamide gel electrophoresis and high LPL activator activity. These C apoproteins from several Sephadex G-200 runs were further separated on a DEAE-Sephacel (Pharmacia) column (I. 6 by 40 cm) using a linear gradient of 0,01-0,2 M Tris-HCI (pH 8'2) in 6 M urea. As soon as practicable, column fractions were tested for LPL activation, as given below, and appropriate fractions pooled and dialysed into 0·01 M Tris-HCI (pH 7· 4), so as to minimize carbamylation.
Isolation oj Human Apo C-IJ
Human apo C-II was isolated from recently frozen plasma obtained from a local blood bank. The method used was· essentially as described for ovine plasma.
Preparation oj Ovine Milk LPL
Lipoprotein lipase was purified from freshly collected ovine milk by affinity chromatography on Sepharose 4B-heparin . The eluted enzyme preparation was kept at -20°C in 0·01 M phosphate buffer (pH 7·4),1·5 M NaCI and 30% (v/v) glycerol at a protein concentration of 0·04 mg/ml. Such preparations were generally diluted lO-fold in 10 mM NH40H-NH4Cl buffer (pH 8 ·1) just prior to commencement of assays.
Assay oj LPL Activity
The determination of LPL activity was carried out essentially as described by Nilsson-Ehle and Schotz (1976) . The reaction mixture (0·2 ml) which contained final concentrations of 67 mM Tris-HCl (pH 8·1),1·5% (w/v) bovine serum albumin, 5·65 mM eH]triolein (or concentrations indicated) and 8·5% (v/v) serum or dilute column fractions, was pre-incubated for 15 min at 25°C prior to addition of 0·1 ml of dilute LPL preparation. Incubations were done at 37°C for 30-60 min, during which time no more than 8% of the triolein was hydrolysed. All assays were performed in duplicate and tubes containing 10 mM NH40H-NH4Cl (pH 8 ·1) instead of the enzyme preparation served as controls. Tubes without serum or activator fractions were always included. The [3H]0Ieic acid released during the reaction was isolated by solvent partition (Belfrage and Vaughan 1969) as modified by NilssonEhle and Schotz (1976) . The radioactivity in the upper phase was determined by liquid scintillation counting, using PCS as scintillant.
In some experiments a water-soluble p-nitrophenyl ester was used as a substrate for LPL catalysis, using essentially the method described by Quinn et al. (1982b) . The reaction (total volume of 1·0 ml) was performed in a glass cuvette at 25°C, and consisted of 0·1 M sodium phosphate buffer (pH 7·2), 0·5 mM p-nitrophenylbutyrate, O· 1 M NaCl, 5 Jl.g heparin and 8 Jl.g ovine milk LPL. Other additions were made as indicated in the text. The hydrolysis of the ester was followed by measuring the absorbance change at 400 nm in a Hewlett-Packard model 8450A UV /VIS spectrophotometer. The rate of the reaction was essentially constant for at least 15 min.
Other Procedures
Urea (Analar grade) was obtained from BDH. Aqueous solutions of 8 M urea were freshly prepared and treated with a mixed-bed resin [Bio-RadAG501-X8(D), 20-50 mesh] before use. Where necessary, dialysis was performed using Spectra/Por 3 tubing with a molecular weight cut-off of 3500, otherwise Visking tubing was used.
Polyacrylamide gel electrophoresis was usually performed in sodium dodecyl sulfate (SDS) according to Laemmli (1970) , but using a linear gradient of 10-22% (w/v) acrylamide. Where indicated, the apoproteins were also separated on alkaline polyacrylamide gels containing urea (Kane 1973) . SDS and urea gels were stained at 25°C for 30 min in 0·25% (w/v) Coomassie (PAGE blue 83, BDH Chemicals Ltd, England) in 10% (v/v) acetic acid, 50% (v/v) methanol. Isoelectric focusing was performed in 7·5% (w/v) acrylamide and 6 M urea as described by Pagnan et al. (1977) and Mills et al. (1984) . Ampholines (pH 4·0-6·5) were obtained from LKB, Uppsala, Sweden. Before staining, gels were fixed overnight in 10% (w/v) trichloroacetic acid, 5% (w/v) sulfosalicylic acid. Gels were stained at 60°C for 1 h in 0·1 % (w/v) Coomassie in 10% (v/v) trichloroacetic acid.
Reagents
Anhydrous emulsions of eH]triolein with glycerol and phosphatidylcholine were prepared as described by Nilsson-Ehle and Schotz (1976) , and stored at 4°C until used. Tri-[9,1O-3 H]0Ieoylglycerol was purchased from Amersham Australia Pty Ltd. Unlabelled triolein was purchased from CalbiochemBehring Corp., California. Bovine serum albumin (Fraction V, Sigma Chemical Co., St Louis, Missouri) was tested for lipase activity before use. Only those preparations essentially free of lipase activity were used. Heparin (158 U.S.P. J-A units/mg), phenylmethylsulfonyl fluoride, 5,5'-dithio-bis(2-nitrobenzoic acid), and p-nitrophenylbutyrate were also purchased from Sigma Chemical Co., St Louis, Missouri. Electrophoresis calibration kits for molecular weight determinations of polypeptides were obtained from Pharmacia Fine Chemicals, Uppsala, Sweden. PCS scintillant was obtained from Amersham Corp., Arlington Heights, Illinois. 
Results
Proteins Bound to Intralipid Particles
Ovine LPL activator was rapidly bound to the washed Intralipid particles. More than 90% of the activity present in the original plasma was removed with the washed lipid particles within 30 min and this did not change with longer incubation. Washing the proteinbound Intralipid essentially resulted in no loss of activator. An identical binding procedure was used for the human plasma and, in each case, approximately 200 mg of proteins were bound to the washed Intralipid particles per litre of plasma. SDS-polyacrylamide gel electrophoresis of the delipidated proteins (Figs la, If) revealed that at least 7-10 major proteins were bound to the Intralipid particles and, in the case of the ovine preparation ... The apoproteins were eluted from the column with a linear gradient of 0'01-0,2 M TrisHCl, pH 8· 2, in 6 M urea. An aliquot of each fifth fraction was assayed for LPL activation (solid line) as described under Methods.
( Fig. 10) , relatively small amounts of the C group of apoproteins (M r c.lO 000) were bound compared with those higher molecular weight proteins. An unknown protein of Mr 78 000 was the major component, but significant amounts of Mr 42000, 27 000 and 22000 proteins were also present. These latter components were tentatively identified as being ovine equivalents of human apoproteins A-IV, A-I and D. In contrast to ovine plasma, the C group of apoproteins were by far the major components bound to Intralipid from human plasma, with lesser amounts of Mr 45000 (apo A-IV), 35000 (apo E) and 28000 (apo A-I) (see Fig. If) . Separation of the apoproteins from the higher molecular weight components was achieved by gel chromatography on Sephadex G200. Usually three major peaks were obtained with each type of preparation, and the C group of apoproteins were shown to be present in the third peak by SDS gradient gel electrophoresis (Figs 1b, 19) . Analysis of the column fractions confirmed that peak 3 contained the activators of LPL. The C group of apoproteins (peak 3) from ovine plasma consisted of at least four proteins of Mr 11 000, 6800, 4800 and 2000 with the Mr 4800 component accounting for about 90% of the total. On the other hand, the C group of apoproteins from human plasma were predominantly of higher molecular weight.
DEAE-Sephacel was then used to separate these proteins on a gradient of 0,01-0,2 M Tris-HCl (pH 8· 2) in 6 M urea. About eight protein peaks were obtained with the ovine preparation, three of which gave activation of LPL (OV 4 , OVs, OV6). These three peaks eluted from the column with about 0·1 M Tris-HCl (Fig. 2a) .
Further analysis of the three active peaks demonstrated that only two activator proteins were present. Ovine fractions OV 4 and OV6 ran on SDS-polyacrylamide gradient gels with apparent Mr of 6000 and 4800 respectively (Figs Ie, Ie) . Ovine fraction OVs contained essentially the protein of OV4 contaminated with a small amount of Mr 11 000 proteins.
Human C group apoproteins were resolved by DEAE-Sephacel into about six protein peaks, the activator being present in two peaks that eluted with about 0·1 M Tris-HCl (Fig. 2b) . Fraction HU 2 gave essentially a single band of apparent Mr 6500 (Fig. 1h) , but fraction HU3 contained the Mr 6500 activator contaminated with a lower molecular weight component (Fig. 11) . These two components were separated by isoelectric focusing, eluted and tested for LPL activation, but only the protein equivalent to HU 2 was active.
Molecular Weights oj Activator Proteins
Ovine plasma thus contains two activator proteins, one of similar apparent molecular weight to the activator from human plasma and the other somewhat smaller. The molecular weight of human apo C-II determined from the amino acid sequence is 8916 (Hospattankar et al. 1984) , but on the SDS gradient gel system used here, it ran corresponding to a molecular weight of 6500 according to the reference standards used (cyanogen bromide fragments of sperm whale myoglobin). Because of this discrepency in molecular weight, the mobility of individual activator proteins relative to the reference peptide mixture was investigated using homogeneous gels (Laemmli 1970 ) over a range of acrylamide concentrations 10, 15, 20 and 25% (w/v) (data not given). At an acrylamide concentration of 10% (w/v), OV4 and HU2 had apparent Mr of 8300 and 8600, but at the higher concentrations ("" 20%) of acrylamide which we used in the gradient gels, the apparent Mr fell to about 6400 and 7000 respectively. The apparent Mr of OV4 was always less than HU 2 and that of the second activator of ovine plasma (OV6) also decreased with increasing acrylamide concentration, from 5200 to 4800. Fig. 3 shows the various activator proteins from ovine and human plasma when separated using a variety of techniques. Gradient gel electrophoresis (Fig. 3a) in the presence of SDS clearly demonstrates the difference in molecular weight between the two ovine activators OV 4 and OV 6' However, with this system, it was not possible to separate mixed samples of ovine OV 4 with the human activator HU2 although the band was somewhat broadened. When run individually, the apparent molecular weight of OV4 was always less than the human activator. Using alkaline-urea gels (Fig. 3b) (Kane 1973 ) the ovine activator OV 4 was well separated from the human activator and the lower molecular weight ovine activator OV 6 migrated between the two. The greatest resolution of the various activators was obtained by iso-electric focusing in urea-containing polyacrylamide gels (pH 4-6' 5) (Fig. 3e) . Ovine activators OV 4 and OV 6 and human activator had pI of 5'1,4'8 and 4'5 respectively. The absolute values varied somewhat between successive runs but the relative mobilities of the proteins remained constant. 
Effectiveness of Activators
The relative effectiveness of the ovine and human activators for the stimulation of LPL was determined using a variety of assay conditions. Ovine milk LPL was incubated at 37°C with triolein at a final concentration of 5·6 mM with either no activator added or with increasing amounts of each of the purified activators. Fig: 4a shows that between 0·1 and 3· 0 p,g ml, each activator behaved identically, approaching maximum effect at about 1·0 p,g/ml. The concentration of activators giving half-maximum velocity was about O' 2 p,g/ml. In the second experiment shown (Fig. 4b) , the concentration of each activator was constant and equal to the amount of LPL present, but the substrate concentration was varied from 0·16 to 5·95 mM triolein. Each activator was equally effective over the range studied. In a third series of experiments (Fig. 5) , the activation of LPL was measured at various ratios of the different activator proteins (OV 4 , OV 6 and HU2) to triolein (0-5' 2 p,g activator protein/mg triolein). For each of the activators OV 4, OV 6 and HU2, a ratio of 1 p,g activator/mg triolein gave essentially full activation at all of the substrate concentrations tested. When the data was plotted according to Lineweaver-Burk, a series of straight lines were obtained for each ratio (p,g activator/mg triolein) indicating that the hydrolysis of the substrate by LPL obeys Michaelis-Menten kinetics (data not shown). Fig. 5d shows the effect of this ratio on the apparent Km values calculated from these lines. It was not possible to calculate an apparent Km value for that measured in the absence of activators as LPL activity per milligram of protein was very low (0' 18-0' 25 p,mol fatty acid/min). However, as the amounts of ovine activators were increased from O· 16 to 5· 2 p,g per mg triolein, the apparent Km fell from c. 0·5 mM to c. 0·18 mM. Human activator protein behaved in a similar manner. As the ratio of activators increased there was a small increase in V max. which did not change with ratios above 1·0.
It is evident that the ovine activator OV 4 has a similar molecular weight to the human activator HU 2 , and is equally effective in stimulating LPL activity, but differs in its pIon isoelectric gels and its mobility on alkaline-urea gels. Whereas human apo C-II markedly stimulates the hydrolysis of long-chain triacylglycerides by LPL, it is not required, and has been shown to inhibit LPL activity, when the water-soluble substrate p-nitrophenylbutyrate is used (Quinn et al. 1982b) . Therefore the effect of the various activator proteins on the hydrolysis of p-nitrophenylbutyrate by ovine milk LPL was determined. The rate of the LPL reaction with p-nitrophenylbutyrate as substrate was o· 12 ± O· 01 ILmol/min per milligram LPL (mean ± s.e.m.; n = 31) at 25°C, only about 1% of the rate obtained . LPL activity as a function of activator protein and triolein concentrations. LPL was assayed as described under Methods using 0·33 p.g LPL per 0·2 ml reaction volume with triolein concentrations of 0·3 mM (_), 0'5 mM (0),1'0 mM (+), 2·0 mM (0), 3·0 mM (e) with (a) ovine activator OV4, (b) ovine activator OV6 or (e) human activator HU2. The apparent Km of LPL for triolein is shown (d) for each of the activator proteins OV4 (_), OV6 (+), HU2 (e) at various ratios of activator to substrate concentrations.
with triolein but comparable to that reported by others (Quinn et al. 1982b) for the soluble substrate. The effect of the activator proteins on the hydrolysis of p-nitrophenylbutyrate expressed as a percentage relative to the reaction rate in their absence is given in the following tabulation (values are expressed as mean ± s.e.m. and the number of assays are indicated in parentheses):
OV 4 (50 p.g/ml) OV 6 (50 p.g/ml) HU2 (30 p.g/ml)
Human activator was almost as effective at 10 ILg/ml, but similar concentrations of ovine activators were without effect.
Discussion
Human fraction HU2 shows all the characteristics of apo C-II. It has an apparent molecular weight similar to that reported for C-II. It stimulates LPL hydrolysis of longchain TAG and causes inhibition of LPL activity when p-nitrophenylbutyrate is used as the reaction substrate. It is an important functional property of apo C-II that it can readily transfer between different lipoproteins (Havel et af. 1973; Eisenberg 1978) . In a similar way, apo C-II present in serum added to in vitro assays of LPL readily transfers to the lipid particles of the TAG emulsion (La Rosa et af. 1970) . This binding of various plasma proteins and apolipoproteins to Intralipid has been studied in some detail (Erkelens et af. 1979; Carlson 1980) . Astrup and Bengtsson (1982) used a phospholipid-depleted Intralipid preparation as the initial step for the large-scale preparation of activator proteins from bovine plasma. This technique offers many advantages over the other procedures which can only deal with small volumes and involve considerable time in the ultracentrifuge. Furthermore, the present study shows that the technique is particularly well suited to those species (e.g. sheep) that have very low plasma concentrations of VLDL. In such cases the bulk of their readily transferable activators reside in the HDL fraction. In contrast, it has been determined that only 50% of the total apo C-II was present in the VLDL-free serum from normotriglyceridemic humans (Kashyap et af. 1977) .
Carlson (1980) showed that Intralipid particles bound essentially only apo C-II and apo C-III when incubated with human serum or VLDL-free serum, but in the work reported here with ovine and human plasma, the C group of apoproteins represented only a small amount of the total proteins bound to the washed Intralipid particles (about 9 and 25% respectively). Astrup and Bengtsson (1982) have also shown that many proteins other than the C group of apoproteins were bound from bovine plasma. In other studies we have used both serum and plasma from sheep and humans with various amounts of Intralipid and this has not . significantly altered the type and quantity of proteins bound (R. K. Tume et af., unpublished observations). Even though other proteins were bound to the Intralipid particles, gel chromatography effectively separated these proteins from the C group of apoproteins, allowing their complete separation on DEAE-Sephacel.
We have demonstrated that ovine plasma contains two distinct activators of LPL having apparent Mr 8300 and 5200 (homogeneous 10% SDS polyacrylamide gels). These low molecular weight proteins were readily separated from each other on the basis of size and charge. Although the presence of isoproteins or molecular variants have been described in several species (Lim and Scanu 1976; Havel et af. 1979) , only in hens egg yolk lipoprotein has any significant size difference been demonstrated (Bengtsson et af. 1977) . The activator components from egg yolk were of similar size to those of ovine plasma, but each egg yolk activator component existed in several charge variants. Attempts to purify these components resulted in loss of activity. Furthermore, the component of hen's yolk lipoprotein of Mr 9000 was in about lO-fold excess of Mr 5000 component whereas the ovine activators were present in about equal amounts.
Human plasma apo C-II exists as a single species of molecular weight 8916 (Hospattankar et af. 1984) but a minor isoelectric variant form has been shown to exist (Havel et af. 1979) . Bovine plasma contains two isoproteins of simliar apparent molecular weight 8000-10 000 (Lim and Scanu 1976; Clegg 1978) which can readily be separated by ionexchange chromatography. Lim and Scanu (1976) and Astrup and Bengtsson (1982) have shown that these bovine activator proteins differ in amino acid composition.
Despite the apparent variability between the activators of different species and between activators within a species, activators show no species specificity when used with a wide variety of lipoprotein lipases (Wallinder et af. 1982; . It is likely therefore that each of these activator proteins has certain regions of specific structural similarities which are highly conserved.
Each of the ovine activators proved to be at least as effective as the human apo C-II in stimulating LPL activity with 1 /Lg/ml giving near maximal activation. Values reported for maximum activation by apo C-II vary widely between various groups, but commonly range from 1 jlg/ml (Matsuoka et al.1981; Wallinder et al. 1982) to more than 40 jlg/ml (Kinnunen et al. 1977) . The relationship between the apparent Km and the activator proteintriolein ratio was the same for all three activator preparations and was similar to that reported for human LPL with apo C-II (Schrecker and Greten 1979) . The two activator proteins obtained from egg yolk lipoproteins by gave half-maximal stimulation at concentrations of 1-2 jlg/ml. In contrast, much higher final concentrations were used in two studies on bovine activator proteins. Lim and Scanu (1976) used up to 50 jlg/ml of each of their activators Dl and D3 and even then obtained respectively only 58 and 18% activation compared with added bovine or human lipoproteins. Clegg (1978) used activator concentrations of 20-25 jlg/ml, and did not obtain more than about 63% of the rate measured in the presence of added serum. Although it is not possible to make absolute comparisons of the effectiveness of the various activators due in part to the different conditions used for assay by various workers, it is clear that each of the ovine activators isolated in this study is at least as active as any human preparation so far reported, and much more active than those isolated from bovine plasma.
There are certain experimental conditions in which LPL is fully active even in the absence of apo C-II. Usually the substrates in these cases are either water-soluble esters or short-chain triacylglycerols, but they appear to be hydrolysed by the same site. Rapp and Olivecrona (1978) demonstrated that tributyrin was hydrolysed by LPL at a high rate whether or not apo C-II was present. Activator protein was not required for hydrolysis of p-nitrophenyl esters (Egelrud and Olivecrona 1973) and also caused significant inhibition of LPL (Quinn et al. 1982b ). Apo C-II was the only apoprotein tested that caused such inhibition. It has been suggested that apo C-II interacts with LPL in such a way that the enzymes' catalytic turnover rate with a water-soluble substrate is reduced. In the present study we used p-nitrophenylbutyrate as substrate in order to compare the ovine activators with human apo C-II. Human apo C-II did cause inhibition of LPL activity but we were unable to observe any change with either of the ovine activators. This suggests that the interaction between each ovine activator and LPL is different from that observed with human apo C-II.
We are interested in the origin, function and structure of these two ovine activators, particularly as they differ so much in molecular size. The smaller activator is likely to contain some 30 amino acid residues fewer than the larger activator (and human apo C-II), yet it still functions as effectively. Studies on synthetic fragments or cyanogen bromide fragments 'of human apo C-II have indicated that two distinct functional domains exist in the entire molecule; one for binding to lipid (residues 43-51, Morrisett et al. 1977; Catapano et al. 1979) , another for the catalytic activation of LPL (residues 56-78, Kinnunen et al. 1977; Catapano et al. 1979) ; both are required for maximal activation. It must be assumed that each of the ovine activators has these two functional regions since they are both as effective as the human apo C-II preparation. The ovine activators therefore offer a unique opportunity to investigate structure-function relationships. The proteins can be relatively easily isolated in pure form and are stable with time of storage.
We are currently determining the sequence of amino acids in each of the ovine activator proteins. Such investigations would determine the similarity of the sequence in the functional regions in the two activators, and establish whether or not the smaller activator has a shorter N-terminal sequence prior to the lipid-binding region. Should the sequence be completely different then it might suggest a different site of synthesis of each activator such as liver and intestine.
